These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 47673)

  • 1. [The hemagglutinin of Clostridium botulinum. Extraction, chemical characteristics and serologic specificity].
    Ivanova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):14-8. PubMed ID: 47673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative immunochemical study of the hemagglutinins of Cl. botulinum A and B].
    Ivanova LG; Kliucheva VV; Blagoveshchenskiĭ VA; Lebedenko GI; Saprykina TP
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):48-53. PubMed ID: 404806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular structure and immunochemical properties of highly purified hemagglutinin from Clostridium botulinum type A].
    Ivanova LG; Blagoveshchenskiĭ VA; Vinogradova ID; Kolesnikova VA; Ugriumova GA
    Biokhimiia; 1983 Sep; 48(9):1548-54. PubMed ID: 6414537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemagglutinin specificity of Cl. botulinum types A, B, and F in reaction with erythrocytes of various animals].
    Blagoveshchenskii BA; Ivanova LG; Khatuntseva NV; Kliucheva VV; Nikitina AA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jul; (7):47-51. PubMed ID: 56111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alteration of the fractional composition and antigenic structure of botulin toxin E in the process of detoxication].
    Sycheva LP; Nemirovich-Danchenko MM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):117-20. PubMed ID: 4207091
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and characterization of Clostridium botulinum type B toxin.
    Beers WH; Reich E
    J Biol Chem; 1969 Aug; 244(16):4473-9. PubMed ID: 4896752
    [No Abstract]   [Full Text] [Related]  

  • 8. ISOLATION AND CHARACTERIZATION OF A TOXIC MOIETY OF LOW MOLECULAR WEIGHT FROM CLOSTRIDIUM BOTULINUM TYPE A.
    GERWING J; DOLMAN CE; BAINS HS
    J Bacteriol; 1965 May; 89(5):1383-6. PubMed ID: 14293025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and some properties of Clostridium botulinum type-E toxin.
    Kitamura M; Sakaguchi S; Sakaguchi G
    Biochim Biophys Acta; 1968 Oct; 168(2):207-17. PubMed ID: 4972262
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of Clostridium botulinum types A and B hemagglutinins by sugars.
    DasGupta BR; Sugiyama H
    Can J Microbiol; 1977 Sep; 23(9):1257-60. PubMed ID: 332296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a hemagglutinin from Amphitrite ornata, a polychaetous annelid.
    Garte SJ; Rissell CS
    Biochim Biophys Acta; 1976 Aug; 439(2):368-79. PubMed ID: 8117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein II. The isolation and characterization of a major antigenic and non-haemagglutinating glycoprotein from Phaseolus vulgaris.
    Pusztai A; Watt WB
    Biochim Biophys Acta; 1970 Jun; 207(3):413-31. PubMed ID: 4989124
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociation studies on the toxin of Clostridium botulinum type B.
    Mitchell B; Gerwing J
    Biochim Biophys Acta; 1969 May; 181(1):336-8. PubMed ID: 4893322
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and properties of an anti-B hemagglutinin produced by Streptomyces sp.
    Fujita Y; Oishi K; Suzuki K; Imahori K
    Biochemistry; 1975 Oct; 14(20):4465-70. PubMed ID: 240402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A pepsin-like proteinase from Aspergillus awamori].
    Lobareva LS; Kovaleva GG; Shimanskaia MP; Stepanov VM
    Biokhimiia; 1972; 37(1):193-208. PubMed ID: 4552965
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preparative isolation and immunochemical study of the O- and H-antigen components of Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Dec; 46(12):51-8. PubMed ID: 4986278
    [No Abstract]   [Full Text] [Related]  

  • 17. MECHANISM OF TRYPTIC ACTIVATION OF CLOSTRIDIUM BOTULINUM TYPE E TOXIN.
    GERWING J; DOLMAN CE; KO A
    J Bacteriol; 1965 May; 89(5):1176-9. PubMed ID: 14292982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cytotoxicity of nonimmune human lymphocytes for sensitized chicken erythrocytes by aggregated human IgG.
    Hallberg T
    Scand J Immunol; 1974; 3(1):117-25. PubMed ID: 4133398
    [No Abstract]   [Full Text] [Related]  

  • 19. Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M
    Infect Immun; 1976 Sep; 14(3):597-602. PubMed ID: 786888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular construction of Clostridium botulinum type A toxins.
    Sugii S; Sakaguchi G
    Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.